MUFG: Fiscal Q1 Earnings Snapshot
- On Thursday, August 6, 2026, Enerflex Ltd., a leading provider of modular natural gas, power technology and treated water solutions, reported its financial results. This report provides key data on the company's performance and guidance for the quarter that just concluded.
- Energy Infrastructure and After-Market Services business lines drove solid operational performance. Enerflex added that the Engineered Systems backlog increased to $1.5 billion, providing strong visibility into future revenue generation and business activity.
- Adjusted EBITDA reached $128 million for the quarter. CFO Preet Dhindsa noted the company extended its revolving credit facility to June 30, 2029, a move "solidifying the Company's financial flexibility."
- Strengthening its portfolio, the company announced the APAC Divestiture of its Asia Pacific operations to its divestiture partner, INNIO Group. This strategic move aims to high-grade the asset base and improve margins, allowing for capital reallocation toward higher-return opportunities.
- Management refined its 2026 capital expenditure guidance to $185 million to $195 million. This reflects a commitment to disciplined capital allocation and investment in profitable growth opportunities, ensuring long-term value creation for shareholders throughout 2026.
196 Articles
196 Articles
D-BOX to Announce First Quarter 2027 Financial Results
MONTREAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the "Company") (TSX: DBO) today announced that it will release its first quarter financial results for the period ended June 30, 2026, after market close on August 11,…
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Strategic milestone advancements for lead clinical candidate PH-762 Initiation of commercial scale API, long term non-clinical toxicology, completion of Phase 1b pharmacology, and new IP announcements King of Prussia, Pennsylvania–(Newsfile Corp. – August 6, 2026) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing […]
Sun Life Financial reports $1B in Q2 profit, rising from $716M last year
TORONTO - Sun Life Financial Inc. says its second-quarter profit was up 41 per cent from last year.
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium



























